Vejle Hospital
🇩🇰Denmark
- Country
- 🇩🇰Denmark
- Ownership
- Private
- Established
- 1890-01-01
- Employees
- -
- Market Cap
- -
A Study on Optimizing Follow-up for Postmenopausal Women With Breast Cancer Treated With Adjuvant Endocrine Therapy
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Behavioral: Individualized, tailored follow-up program
- First Posted Date
- 2016-10-18
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Vejle Hospital
- Target Recruit Count
- 134
- Registration Number
- NCT02935920
- Locations
- 🇩🇰
Vejle hospital, Department of Oncology, Vejle, Region Of Southen Denmark, Denmark
Individual Survivorship Program for Ovarian Cancer Patients Based on PROM's and Shared Decision Making
Completed
- Conditions
- Ovarian CancerQuality of LifePROM
- First Posted Date
- 2016-09-28
- Last Posted Date
- 2022-03-11
- Lead Sponsor
- Vejle Hospital
- Target Recruit Count
- 223
- Registration Number
- NCT02916875
- Locations
- 🇩🇰
Department of Oncology, Vejle Hospital, Vejle, Denmark
Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer
Phase 2
Completed
- Conditions
- Breast Cancer
- Interventions
- Dietary Supplement: Tocotrienol 300 mg x 3 daily
- First Posted Date
- 2016-09-21
- Last Posted Date
- 2021-05-20
- Lead Sponsor
- Vejle Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT02909751
- Locations
- 🇩🇰
Vejle hospital, Department of Oncology, Vejle, Denmark
Shared Decision Making With Anal Cancer Patients on Radiation Dose
Not Applicable
Active, not recruiting
- Conditions
- Anal Cancer
- Interventions
- Radiation: 2.15 gray and 1.8 gray. Max. 6 weeks.Radiation: 2.15 gray and 1.8 gray. Max. 5 weeks.
- First Posted Date
- 2016-05-27
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Vejle Hospital
- Target Recruit Count
- 27
- Registration Number
- NCT02785263
- Locations
- 🇩🇰
Vejle Hospital, Vejle, Denmark
Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer
Phase 2
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Dietary Supplement: TocotrienolDrug: Placebo
- First Posted Date
- 2016-03-10
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- Vejle Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT02705300
- Locations
- 🇩🇰
Department of Oncology, Vejle Hospital, Vejle, Denmark
Tocotrienol as a Nutritional Supplement in Patients With Advanced Lung Cancer
Phase 3
Terminated
- Conditions
- Lung Cancer
- Interventions
- Dietary Supplement: Tocotrienol 300 mg x 3 daily until progressionDrug: Placebo 1 capsule x 3 daily until progression
- First Posted Date
- 2015-12-31
- Last Posted Date
- 2021-05-03
- Lead Sponsor
- Vejle Hospital
- Target Recruit Count
- 79
- Registration Number
- NCT02644252
- Locations
- 🇩🇰
Department of Oncology, Vejle Hospital, Vejle, Denmark
Psychomotor Therapy as Complimentary Treatment to Patients With Shoulder Pain.
Not Applicable
Completed
- Conditions
- Shoulder Pain
- Interventions
- Other: Psychomotor therapyOther: PhysiotherapyDrug: corticosteroid injection
- First Posted Date
- 2015-12-14
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Vejle Hospital
- Target Recruit Count
- 88
- Registration Number
- NCT02629783
- Locations
- 🇩🇰
Shoulder clinic, Orthopedic department, Hospital Lillebaelt - Vejle Hospital, Vejle, Jutland, Denmark
NIV-NAVA vs NIV-PS/PC in Respiratory Insufficiency
Completed
- Conditions
- Acute Respiratory InsufficiencyRespiratory Insufficiency
- Interventions
- Other: NIV-NAVAOther: NIV-PS/PC
- First Posted Date
- 2015-10-30
- Last Posted Date
- 2017-07-12
- Lead Sponsor
- Vejle Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT02592512
- Locations
- 🇩🇰
Vejle Hospital, Vejle, Southern jetland, Denmark
Cabazitaxel in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.
- First Posted Date
- 2015-09-25
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Vejle Hospital
- Target Recruit Count
- 26
- Registration Number
- NCT02560337
- Locations
- 🇩🇰
Vejle Hospital, Department of Oncology, Vejle, Denmark
Curative Chemoradiation of Low Rectal Cancer
Active, not recruiting
- Conditions
- Rectal Cancer
- First Posted Date
- 2015-05-08
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Vejle Hospital
- Target Recruit Count
- 105
- Registration Number
- NCT02438839
- Locations
- 🇩🇰
Department of Oncology, Aalborg University Hospital, Aalborg, Denmark
🇩🇰Department of Oncology, Vejle Hospital, Vejle, Denmark
🇩🇰Department of Oncology, Rigshospitalet, Copenhagen, Denmark
© Copyright 2025. All Rights Reserved by MedPath